Insider trades
John Mendlein, Director of Fate Therapeutics FATE, has filed 2 purchases and 0 sales on the open market. The latest trade was on 25/05/29.
John Mendlein
Director
- Company
- Fate Therapeutics FATE
- First filing
- 23/01/13
- Trades
- 9 trades
- Buys / sales
- 2 / 0
- 12-month net buying
- No record
- Last trade
- 25/05/29
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
FATE | Open-market buy | 23/01/11–23/01/13 | 23/01/13 | 124,679 sh2 trades | $5.60avg. | $698,138.49 | +78.9% |